These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36791278)

  • 21. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes.
    Simon K; Merten N; Schröder R; Hennen S; Preis P; Schmitt NK; Peters L; Schrage R; Vermeiren C; Gillard M; Mohr K; Gomeza J; Kostenis E
    Mol Pharmacol; 2017 May; 91(5):518-532. PubMed ID: 28254957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Heterodimerization between the G Protein-Coupled Receptor GPR17 and the Chemokine Receptors 2 and 4: New Evidence.
    Daniele S; Saporiti S; Capaldi S; Pietrobono D; Russo L; Guerrini U; Laurenzi T; Ataie Kachoie E; Palazzolo L; Russo V; Abbracchio MP; Eberini I; Trincavelli ML
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment.
    Nguyen P; Doan P; Rimpilainen T; Konda Mani S; Murugesan A; Yli-Harja O; Candeias NR; Kandhavelu M
    J Med Chem; 2021 Aug; 64(15):10908-10918. PubMed ID: 34304559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.
    Ceruti S; Villa G; Genovese T; Mazzon E; Longhi R; Rosa P; Bramanti P; Cuzzocrea S; Abbracchio MP
    Brain; 2009 Aug; 132(Pt 8):2206-18. PubMed ID: 19528093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17.
    Daniele S; Lecca D; Trincavelli ML; Ciampi O; Abbracchio MP; Martini C
    Cell Signal; 2010 Apr; 22(4):697-706. PubMed ID: 20056144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
    Daniele S; Trincavelli ML; Fumagalli M; Zappelli E; Lecca D; Bonfanti E; Campiglia P; Abbracchio MP; Martini C
    Cell Signal; 2014 Jun; 26(6):1310-25. PubMed ID: 24613411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.
    Eberini I; Daniele S; Parravicini C; Sensi C; Trincavelli ML; Martini C; Abbracchio MP
    J Comput Aided Mol Des; 2011 Aug; 25(8):743-52. PubMed ID: 21744154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.
    Simon K; Hennen S; Merten N; Blättermann S; Gillard M; Kostenis E; Gomeza J
    J Biol Chem; 2016 Jan; 291(2):705-18. PubMed ID: 26620557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
    Coppi E; Maraula G; Fumagalli M; Failli P; Cellai L; Bonfanti E; Mazzoni L; Coppini R; Abbracchio MP; Pedata F; Pugliese AM
    Glia; 2013 Jul; 61(7):1155-71. PubMed ID: 23640798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.
    Cosentino S; Castiglioni L; Colazzo F; Nobili E; Tremoli E; Rosa P; Abbracchio MP; Sironi L; Pesce M
    J Cell Mol Med; 2014 Sep; 18(9):1785-96. PubMed ID: 24909956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico analysis of the interaction of avian aryl hydrocarbon receptors and dioxins to decipher isoform-, ligand-, and species-specific activations.
    Hirano M; Hwang JH; Park HJ; Bak SM; Iwata H; Kim EY
    Environ Sci Technol; 2015 Mar; 49(6):3795-804. PubMed ID: 25692546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the molecular mechanism of umami recognition by T1R1-T1R3 using molecular dynamics simulations.
    Liu H; Da LT; Liu Y
    Biochem Biophys Res Commun; 2019 Jun; 514(3):967-973. PubMed ID: 31092329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of select oxysterols as ligands for GPR17.
    Harrington AW; Liu C; Phillips N; Nepomuceno D; Kuei C; Chang J; Chen W; Sutton SW; O'Malley D; Pham L; Yao X; Sun S; Bonaventure P
    Br J Pharmacol; 2023 Feb; 180(4):401-421. PubMed ID: 36214386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like Growth Factor 1 Promotes Cell Proliferation by Downregulation of G-Protein-Coupled Receptor 17 Expression via PI3K/Akt/FoxO1 Signaling in SK-N-SH Cells.
    Lin KN; Zhang K; Zhao W; Huang SY; Li H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial complex III bypass complex I to induce ROS in GPR17 signaling activation in GBM.
    Kari S; Kandhavelu J; Murugesan A; Thiyagarajan R; Kidambi S; Kandhavelu M
    Biomed Pharmacother; 2023 Jun; 162():114678. PubMed ID: 37054539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand-dependent intracellular trafficking of the G protein-coupled P2Y
    Girard M; Bellefeuille SD; Eiselt É; Arguin G; Longpré JM; Sarret P; Gendron FP
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119476. PubMed ID: 37059189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
    Nguyen ED; Norn C; Frimurer TM; Meiler J
    PLoS One; 2013; 8(7):e67302. PubMed ID: 23844000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation.
    Meraviglia V; Ulivi AF; Boccazzi M; Valenza F; Fratangeli A; Passafaro M; Lecca D; Stagni F; Giacomini A; Bartesaghi R; Abbracchio MP; Ceruti S; Rosa P
    Glia; 2016 Aug; 64(8):1437-60. PubMed ID: 27270750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking and molecular dynamics simulation studies of GPR40 receptor-agonist interactions.
    Lu SY; Jiang YJ; Lv J; Wu TX; Yu QS; Zhu WL
    J Mol Graph Model; 2010 Jun; 28(8):766-74. PubMed ID: 20227312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.